Trial Profile
Efficacy and safety of PEG-Inferon (peginterferon alpha-2b) for the treatment of chronic hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Virchow Group
- 26 Jan 2011 New trial record